Considerations for Clinical Trial Design in Relapsed and Refractory Osteosarcoma: An FDA Symposium.
This publication is a concise report from an FDA Oncology Center of Excellence mini‑symposium held in May 2023 focused...
This publication is a concise report from an FDA Oncology Center of Excellence mini‑symposium held in May 2023 focused...
This publication is a narrative overview highlighting the role of physiotherapy in managing common, function-limiting si...
This multicenter Japanese study evaluated short‑term psychological impact of multigene panel cascade testing on 123 fi...
This publication is a narrative overview of current and emerging strategies in fertility preservation and how they fit i...
This study characterizes a distinct, clinically relevant subset of tumor-associated macrophages that express CD19 and ar...
Phase II neoadjuvant trial of serplulimab + SOX + thymalfasin in cStage III gastric/GEJ adenocarcinoma Design: - Prospe...